Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
GliomaGlioblastoma
Interventions
DEVICE

Readiband Sleep Tracking

Once a patient has consented to study progression, a Readiband™ Sleep Tracker device will be provided to the patient, along with necessary instructions. Patients will return home with the device and fatigue data will be obtained from the device at subsequent standard care follow-up visits. In addition, surveys related to fatigue and quality of life will be administered via secure electronic survey to participants.

Trial Locations (1)

55407

Abbott Northwestern Hospital, Minneapolis

All Listed Sponsors
lead

Allina Health System

OTHER

NCT03877861 - Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms | Biotech Hunter | Biotech Hunter